Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Anemia · Anemia Associated With Chronic Kidney Disease · AKBA

Akebia Europe

Akebia Europe Limited

Akebia Europe clinical programs — 25 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
2007 Founded
271 Employees
Public company Type
AKBA · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Founded
2007
Employees
271
Programs
25
Drugs
13
Patents
28
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Akebia Europe projects

25 ClinicalTrials.gov programs sponsored by Akebia Europe.

Akebia Europe has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

25 programs

Clinical programs

  1. Epoetin alga (Epogen)/vadadustat

    Akebia Europe Limited

    Anemia Associated With Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  2. Erythropoiesis-Stimulating Agent (ESA)

    Akebia Europe Limited

    Anemia of Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  3. Ferric Citrate 1 GM Oral Tablet [AURYXIA]

    Akebia Europe Limited

    Anemia, Iron Deficiency

    phase 3 small molecule completed

    1 trial

  4. Vadadustat

    Akebia Europe Limited

    Anemia

    phase 3 small molecule completed

    10 trials

  5. Vadadustat

    Akebia Europe Limited

    Anemia Associated With Chronic Kidney Disease (CKD)

    phase 3 small molecule completed

    1 trial

  6. Vadadustat

    Akebia Europe Limited

    Anemia of Chronic Kidney Disease

    phase 3 small molecule active

    3 trials

  7. Vadadustat 900mg

    Akebia Europe Limited

    Nonintubated Acute Respiratory Distress Syndrome (ARDS)

    phase 3 small molecule active

    1 trial

  8. AKB-6548

    Akebia Europe Limited

    Anemia

    phase 2 small molecule completed

    4 trials

  9. IW-1973

    Akebia Europe Limited

    Type 2 Diabetes Mellitus With Diabetic Nephropathy

    phase 2 small molecule completed

    1 trial

  10. IW-1973

    Akebia Europe Limited

    Heart Failure With Preserved Ejection Fraction

    phase 2 small molecule completed

    1 trial

  11. Praliciguat

    Akebia Europe Limited

    Focal Segmental Glomerulosclerosis

    phase 2 small molecule active

    1 trial

  12. Vadadustat

    Akebia Europe Limited

    Chronic Kidney Disease

    phase 2 small molecule completed

    1 trial

  13. vadadustat

    Akebia Europe Limited

    Acute Respiratory Distress Syndrome

    phase 2 small molecule completed

    1 trial

  14. AKB-6548

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. AKB-6548 (therapeutic dose)

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. AKB-6548-CI-0013

    Akebia Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  17. AKB-9090

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  18. Celecoxib

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  19. Vadadustat

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. Vadadustat

    Akebia Europe Limited

    Anemia Associated With Chronic Kidney Disease

    phase 1 small molecule completed

    1 trial

  21. Vadadustat

    Akebia Europe Limited

    Drug Interaction Potentiation

    phase 1 small molecule completed

    4 trials

  22. Vadadustat

    Akebia Europe Limited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  23. vadadustat

    Akebia Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  24. vadadustat reference tablets

    Akebia Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  25. Ferric Citrate 1 gram Oral Tablet

    Akebia Europe Limited

    Hyperphosphatemia

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Akebia Europe have?

25 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.